Angeion setting up clinical sites for RF ablation catheter study.
This article was originally published in The Gray Sheet
Executive Summary
ANGEION ESTABLISHING CLINICAL SITES FOR RF ABLATION CATHETER STUDY okayed by FDA under a recently approved investigational device exemption. On Feb. 22, the firm announced that FDA approved an IDE for a Phase I trial that will include up to 20 radiofrequency ablation procedures in four centers.